“Wonder Herb” Boosts Heart Attack Recovery
After a heart attack, your body is flooded with inflammation.
Doctors prescribe powerful anti-inflammatories to help combat it.
The problem is, they ALSO suppress your immune system in the process, increasing your risk of severe infections.
And let’s face it, the last thing you need when recovering from a heart attack is to battle an infection.
But there could be a BETTER option.
Researchers have uncovered a “wonder herb” that SAFELY slashes inflammation while ENHANCING immune function.
This study was a randomized, controlled pilot study that included 90 patients over 65. The participants received either a patented herbal compound called TA-65 or a placebo.
The product is derived from a traditional Chinese plant called Astragalus.
The volunteers took the Astragalus supplement for more than a year after having a heart attack, and it produced some remarkable results. They saw:
- A 62 percent reduction in inflammation.
- A boost in the production of vital immune cells called lymphocytes.
- A reduction in post heart-attack complications like chest and joint pain.
- Thirty percent fewer adverse effects like fever and new medical problems after their heart attack.
You see, inflammation plays a significant role in the formation, progression, and rupture of the coronary artery plaques that CAUSE a heart attack in the first place.
But that same inflammation also hangs around AFTER the attack, continuing to wreak havoc and contributing to even more complications.
Because of this, dialing down inflammation is vital for both REDUCING the risk of heart attacks and TREATING patients after one has occurred.
Ask your doctor about cutting back on risky anti-inflammatory drugs and using safe and effective Astragalus instead.
P.S. It can seem like a heart attack strikes without warning. But the body often raises subtle red flags that are easy to miss. Beware of these 12 heart attack early warning signs.
SOURCE:
“Activation of telomerase by TA-65 enhances immunity and reduces inflammation post myocardial infarction.” GeroScience (2023). https://doi.org/10.1007/s11357-023-00794-6